These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 28392335
1. Graves' disease in a 3 year-old patient with agranulocytosis due to anti-thyroid drugs: Radioiodine ablation therapy as an effective alternative. Espinosa-Muñoz E, Ramírez-Ocaña D, Martín-García AM, Ruiz-García FJ, Puentes-Zarzuela C. Rev Esp Med Nucl Imagen Mol; 2017; 36(4):260-262. PubMed ID: 28392335 [Abstract] [Full Text] [Related]
2. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy. Sabri O, Zimny M, Schreckenberger M, Reinartz P, Ostwald E, Buell U. Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656 [Abstract] [Full Text] [Related]
3. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years]. Cepková J, Gabalec F, Svilias I, Horáček J. Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005 [Abstract] [Full Text] [Related]
4. Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia. Rahman MA, Birrell G, Stewart H, Lucraft H, Cheetham TD. Arch Dis Child; 2003 Feb; 88(2):158-9. PubMed ID: 12538324 [Abstract] [Full Text] [Related]
5. Influence of prior carbimazole on the outcome of radioiodine therapy in pediatric and adolescent Graves' disease. Ballal S, Soundararajan R, Singh H, Garg A, Chopra S, Bal C. Nucl Med Commun; 2015 Jun; 36(6):566-72. PubMed ID: 25757198 [Abstract] [Full Text] [Related]
6. Agranulocytosis associated with anti-thyroid drug in patients with Graves' thyrotoxicosis--report of 11 cases. Li KL, Huang HS, Wang PW, Lin JD, Juang JH, Liu RT, Huang BY, Huang MJ. Changgeng Yi Xue Za Zhi; 1991 Sep; 14(3):168-73. PubMed ID: 1718579 [Abstract] [Full Text] [Related]
7. Neutropenia Occurs More Often Under Carbimazole than Under Methimazole Treatment in Pediatric Graves' Disease Patients. Schempp V, Cebeci AN, Reinauer C, Woelfle J, Dörr HG, Roosen MT, Gohlke J, Gohlke B. Thyroid; 2024 Jun; 34(6):735-743. PubMed ID: 38613811 [Abstract] [Full Text] [Related]
8. Should radioiodine be the first-line treatment for paediatric Graves' disease? West JD, Cheetham TD, Dane C, Natarajan A. J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):797-804. PubMed ID: 25719296 [Abstract] [Full Text] [Related]
9. Successful treatment of a patient with Graves' disease on hemodialysis complicated by antithyroid drug-induced granulocytopenia and angina pectoris. Miyasaka Y, Yoshimura M, Tabata S, Shozu A, Nishikawa M, Iwasaka T, Inada M. Thyroid; 1997 Aug; 7(4):621-4. PubMed ID: 9292952 [Abstract] [Full Text] [Related]
10. Graves' disease in adults Antithyroid drugs, radioactive iodine, or sometimes thyroidectomy. Prescrire Int; 2017 Mar; 26(180):72-77. PubMed ID: 30730622 [Abstract] [Full Text] [Related]
11. Outcome of treatment of hyperthyroidism. Bringmann IM, van Leeuwen BL, Hennemann G, Beckett GJ, Toft AD. J Endocrinol Invest; 1999 Apr; 22(4):250-6. PubMed ID: 10342357 [Abstract] [Full Text] [Related]
12. Fatality complicating agranulocytosis in the setting of carbimazole therapy. Lynch MJ, Woodford NW. Forensic Sci Med Pathol; 2008 Apr; 4(4):246-9. PubMed ID: 19291446 [Abstract] [Full Text] [Related]
13. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents]. Sabri O, Zimny M, Schreckenberger M, Reinartz P, Nowak B, Ostwald E, Schäfer W, Block S, Setani K, Büll U. Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933 [Abstract] [Full Text] [Related]
14. Graves' Disease Pharmacotherapy in Women of Reproductive Age. Prunty JJ, Heise CD, Chaffin DG. Pharmacotherapy; 2016 Jan; 36(1):64-83. PubMed ID: 26799350 [Abstract] [Full Text] [Related]
15. Diagnosis and treatment of Graves disease. Streetman DD, Khanderia U. Ann Pharmacother; 2003 Jan; 37(7-8):1100-9. PubMed ID: 12841824 [Abstract] [Full Text] [Related]
16. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE. J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492 [Abstract] [Full Text] [Related]
17. [Hypersensitivity syndrome : a rare but severe adverse effect of antithyroid drugs]. Vinzio S, Goichot B, Andrès E, Schlienger JL. Ann Endocrinol (Paris); 2000 May; 61(2):151-3. PubMed ID: 10891666 [Abstract] [Full Text] [Related]
18. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole. Vilchez FJ, Torres I, Garcia-Valero A, López-Tinoco C, de Los Santos A, Aguilar-Diosdado M. Ann Pharmacother; 2006 Nov; 40(11):2059-63. PubMed ID: 17077174 [Abstract] [Full Text] [Related]
19. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Takata K, Kubota S, Fukata S, Kudo T, Nishihara E, Ito M, Amino N, Miyauchi A. Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623 [Abstract] [Full Text] [Related]
20. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children]. Chen DY, Chen TH. Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551 [Abstract] [Full Text] [Related] Page: [Next] [New Search]